Article
Clinical implications of high-risk mutations in drug resistant tuberculosis (DR-TB): An observational cohort study.
Indian journal of medical microbiology - 1 Jan 2000
Thampy Anupa, Ninan Marilyn M, Michael Joy S, James Prince, Rupali Priscilla
Abstract excerpt
Genotype MTBDRsl [SL-LPA] was endorsed as a tool for early diagnosis of fluoroquinolones (FQ) and injectable second-line TB drugs (SLID) resistance in DR-TB. Correlation between specific genetic mutations using this tool and clinical outcome has not hitherto been studied in India. We conducted a observational cohort study to evaluate the predictive value of specific mutations for bad outcome. Our study identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
